We identified 16 novel mutations in SGCA, SGCB, and SGCG in 25 patients, who showed a broad spectrum of clinical phenotypes, and identified for the first time a patient with coexistence of LGMD2D and CMT1A. This evidence concerns the gene PMP22 and autosomal recessive limb-girdle muscular dystrophy type 2D.